Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysis

Felismino, TC; de Jesus, VHF; Uchoa, BCD; Moura, FGR; Riechelmann, RP; Aguiar, S; de Mello, CAL

Felismino, TC (corresponding author), AC Camargo Canc Ctr, Dept Med Oncol, Sao Paulo, Brazil.

ECANCERMEDICALSCIENCE, 2020; 14 ():

Abstract

Background: CAPOX regimen is a standard option in stage III adjuvant colon cancer. Gastrointestinal toxicity is well described with fluoropyrimidine r......

Full Text Link